Background: Breast augmentation surgery remains the most frequently performed aesthetic surgical procedure worldwide. However, many variations exist regarding preoperative planning, surgical management, and postoperative care. Objectives: The goal was to evaluate current trends and practices in breast augmentation, with a focus on international variability. Methods: A questionnaire was sent to over 5000 active breast surgeons in 44 countries worldwide. The survey inquired about current controversies, new technologies, common practices, secondary procedures, and surgeon demographics. The findings and variations were evaluated and correlated to evidence-based literature.
Recently, Hidalgo et al conducted a US-based study evaluating current breast augmentation trends and pointed out that while certain most common surgical approaches exists, new technologies are only slowly integrated into daily practice. 12 The aim of this study was to compare breast augmentation techniques on an international level and to the previously published US-based data of Hidalgo and Sinno, in order to further standardize this procedure according to evidence-based guidelines.
METHODS
A 38-item, online survey was designed (D.H.) and the questionnaire sent to 5052 active breast surgeons in 44 countries, using a professional e-mail marketing service (Mailchimp, Atlanta, GA, USA). Surgeons were contacted by e-mail correspondence through contact listings in national and international specialty societies, which were chosen based on the size of their listed members (>500). Societies without public listings were contacted directly to inquire about their members and respective e-mail addresses ( Table 1 ). The survey addressed 5 areas of interest: current controversies, new technologies, common practices, technical considerations in secondary procedures, and member demographics. It was launched on June 1, 2016 and reminders were sent 4, 8, and 12 weeks later. The survey was closed on December 31, 2016. Responses were anonymous and the results were tabulated using Microsoft Excel (Microsoft Corp., Redmond, WA). Questions that included a commentary option were studied individually to uncover relevant issues potentially overlooked by question design. A blank copy of the survey is available online as Supplementary Material at www. aestheticsurgeryjournal.com.
RESULTS
A total of 628 responses were gathered. To enhance statistical power, the single countries were grouped by major geographic regions into Latin America (n = 139), Europe (n = 341), Asia (n = 90), and Oceania (n = 58), 13 and then compared to the US-based data of Hidalgo and Sinno. 12 A total response rate of 12.3% was obtained, which needs to be adjusted due to high bounce rates of the recipients' e-mail servers of up to 30%. Taking the mean bounce rate into consideration, a response rate of approximately 18% was achieved. The response rates for each of the 4 email campaigns were 7%, 7%, 2%, and 2%, respectively. Only fully completed questionnaires were included in the analysis. Surgeon experience was distributed reasonably even among the 6 intervals of practice time surveyed, although over one third of respondents of all regions reported a work experience of more than 20 years.
In all regions, the practice type was solo in the majority of surgeons (United States, 52%; Latin America, 48%; Oceania, 48%; and Asia and Europe: 31%). In Latin America, Europe, and Asia practice type was similar regarding solo practice, shared facility and small plastic surgery group (about 20% of respondents). In the United States, the small plastic surgery group (20%) was the second most common practice pattern, and in Oceania it was the solo-practice−shared facility (38%).
In the United States and Europe, practice types were distributed evenly when disregarding the 2% (United States) and 4% (Europe) solely reconstructive practices, whereas in Latin America most respondents (45%) perform 75% cosmetic and 25% reconstructive surgery. In Oceania almost half of surgeons practices (42%) are 50% cosmetic and 50% reconstructive oriented, while in Asia practices are more reconstructive oriented.
Except for the United States, the majority of surgeons perform no more than 50 augmentations per year (Asia, 89%; Oceania, 72%; Latin America, 63%; Europe, 60%; and the United States, 49%). About a third of respondents in the United States (36%), Europe (34%), and Latin America (30%) perform between 51 and 150 breast augmentations annually (Table 2 ).
In the United States and Latin America, about half of all respondents never use anatomically shaped implants, and the vast majority of the remainder use them less than half the time, whereas in Europe, Asia, and Oceania their use is much more common (Figure 1) .
The 3 greatest concerns regarding anatomical implant use in Europe, Asia, and Oceania (in order) were the malrotation potential, the lack of proof for aesthetic superiority compared with round implants, and the higher cost. In the United States, higher cost was the second most common concern and in Latin America it was the lack of proof for aesthetic superiority.
Regarding the use of autologous fat solely as a primary breast augmentation technique, in the United States, Latin America, and Oceania it is used by less than 25% of respondents. For those that do consider it, the vast majority use it less than 50% of the time. In contrast, in Europe and Asia over 50% of surgeons use it ( Figure 2) .
The greatest objections to solely fat grafting included the possible need for multiple procedures, the limited augmentation potential, and cost, with different reasoning within the given countries. For instance, in Latin America most respondents (60%) pointed out the limited augmentation potential of fat grafting, in Asia, cost was considered the major limiting factor.
Regarding the use of autologous fat as a supplemental technique together with implants, in the United States and in Oceania more than half of respondents do not use it at all. In Europe and Asia it was the opposite, with about 2/3 at least sometimes using it.
However, there was also international agreement. In all regions, the majority of respondents (53% to 69%) thought that implants have no negative effect on the reading of mammographies. Only in Oceania 40% of respondents believed that it can impair readings.
Regarding deep venous thrombosis, about one third of respondents in the United States and Europe, and 41% of respondents in Latin America and 57% in Asia would choose not to perform breast augmentation on a factor V Leiden heterozygous patient. In Oceania, only 17% would not operate on such a patient. In all regions, the remainder would choose to do so using sequential compression devices at the very least. About half of all respondents would add anticoagulation/chemoprophylaxis as an additional preventive measure. Lastly, between 2 (Asia) and 14 (Oceania) percent of surgeons have encountered a case of anaplastic large cell lymphoma (ALCL) in their practice (Table 3) .
Overall, only few surgeons currently use 3D imaging in their practice, except for in Oceania where about 43% use it (Figure 3 ). The most important advantages cited by users in all regions were that it is an effective tool for marketing, patient education, and sizing.
Almost 60% of surgeons in the United States work with acellular dermal matrices for revision procedures or in secondary breast augmentation, whereas in all other regions the majority do not use such materials (Figure 4 ).
In the United States, the most common indications (in descending order) to use acellular dermal matrices (ADMs) included as a capsulorrhaphy buttress, to treat ripples or thin tissues, and in cases of capsular contracture, while in most other regions rippling and contour deformities were mentioned first.
More than half of surgeons worldwide do not use funnels for implant insertion (Europe, 83%; Asia, 76%; Latin America, 75%; and the United States, 52%), whereas in Oceania their use is much more common ( Figure 5 ). For the majority of nonusers, the most common objections were that they are believed not to be necessary and carry extra cost. The use of protective plastic sheeting was another matter of discordance, with in Latin America only 25% using it, while in other countries the rate was up to 60% (Oceania). Most surgeons use it to cover the nipple-areola complex, and a much smaller number to cover the incision area (Table 4) .
Most surgeons surveyed prefer either round silicone implants, silicone forms, or tissue-based systems for preoperative sizing, only in Europe and Oceania sizing with silicone forms is more common. "Rice bags" are rarely employed (4% to 22%), and even fewer surgeons either use 3D imaging or no method at all. Worldwide, over 80% of surgeons use 100% silicone implants only, whereas in the United States only 22% use that type only. Similarly striking was the different preference regarding implant shell surfaces ( Figure 6 ).
In the United States and Oceania, over two thirds of surgeons usually use implant sizes greater than 300 cc (in the United States 36% of respondents uses implant sizes even greater than 350 cc), whereas in Europe and Asia surgeons mostly use volumes smaller than 300 cc.
Inframammary incisions were in all regions by far the most common approaches to create an implant pocket and the second most common was the periareolar incision.
In most instances, partial submuscular pockets are dissected, except for in Latin America, where the subglandular location is preferred. The subfascial pocket plane is overall rarely used, except for in Latin America and Asia ( Figure 7) .
Over 93% of all respondents administer intravenous antibiotics at induction of anesthesia, and almost two thirds use postoperative antibiotics. In the United States, pocket irrigation with classic triple-antibiotic solution is performed by 53%, whereas in all other regions it was only used by 7% (Asia) to 24% (Oceania) of surgeons. Povidone-iodine, either with or without additional antibiotics, is irrigation of choice for about one third of surgeons (except for in Latin America). 
Characteristic
Latin America (% of total respondents, n = 139) Europe (% of total respondents, n = 341) Asia (% of total respondents, n = 90) Oceania (% of total respondents, n = 58) In the United States and Asia, more than half of respondents recommend a postoperative implant massage regimen, while in all other countries the majority of surgeons do not. Regarding nonsurgical methods for treating capsular contracture, many surgeons in the United States and Asia begin with massage therapy, in Oceania and Europe the majority of surgeons think that there is no nonsurgical treatment method. Similarly, pharmacologic agents are administered by about half of surgeons in the United States and Latin America, while in Europe (79%), Asia (78%), and Oceania (97%), most respondents never use them ( Table 5) .
The most common reasons to perform a reoperation were quoted to be capsular contracture and need for a size change. In all regions, first-time capsular contracture is usually treated by either anterior capsulectomy (29% to 46%) or total capsulectomy (35% to 44%). The third commonly selected surgical technique was the neopocket formation. Recurrent contracture is typically approached by capsulectomy and neopocket formation, while to treat a double-bubble deformity or bottoming-out, capsulorrhaphy alone is the preferred option (Table 6 ). 
Latin America (% of total respondents, n = 139) Europe (% of total respondents, n = 341) Asia (% of total respondents, n = 90) Oceania (% of total respondents, n = 58) 
DISCUSSION
Breast augmentation is an increasingly common performed operation, but apparently there exists significant international discordance regarding several aspects of the procedure. This may be due to a variety of reasons, including: 1) Surgeons preference based on training, experience and tradition 2) Cost 3) Hesitance to embrace new technology for personal as well as potentially legal reasons (different healthcare systems) 4) Lack of knowledge regarding established standards
The assumption that trends are geographically based was one of the working hypotheses. It appears that such trends, be it fashion, design, or technology, usually have a place of origin and then spread. Regarding aesthetic surgery, in many instances, trends arguably emerge in the United States. It was therefore one of the aims to evaluate if there exist current practice preferences in the United States which are, based on current literature, common standards and soon to be established elsewhere or vice versa. Comparing the United States to the rest of the world would be possible, but given the potential influence of different cultures and ethnic backgrounds, we opted to present the responses broken down. Unfortunately, information regarding location of practice of the surgeons was not obtained on a state level, so trends within the United States could not be analyzed in further detail.
In this setting, the ongoing debate when to use which type of implant is certainly one of the most controversial and relevant issues, as choosing the right implant shape is a key decision. Besides volume, breast proportion and shape play the major roles to achieve an aesthetically pleasing outcome. Anatomical and round prosthesis can be used successfully, 14 #8232;and the surgeon should assess the potential benefits of both types during the surgical planning process. In 2015, Hedén et al discussed some misconceptions regarding anatomical implants and stated that they should primarily be used in cases of poor soft tissue coverage, tuberous breasts, or a short lower pole. 15 A widespread opinion is that anatomic implants will create a more natural look, but are associated with the possibility of malrotation (estimated risk between 5.2% and 14%). However, with appropriate surgical planning and techniques, these risks can be minimized. [16] [17] [18] Despite these facts, when evaluating the aesthetic results and patient satisfaction comparing anatomically shaped and round implants, 19 several authors observed the inability to visually identify the type of implant used. [20] [21] [22] This discrepancy also becomes apparent in the presented survey population. About 90% of surgeons in the United States and Latin America never use anatomically shaped implants, whereas 
Characteristic
Latin America (% of total respondents, n = 139) Europe (% of total respondents, n = 341) Asia (% of total respondents, n = 90) Oceania (% of total respondents, n = 58) Table 5 . Continued in Europe, Asia, and Oceania 22% to 46% of surgeons do. One third of European surgeons even use them more than half the time, and smaller implants tend to be used in lower BMI patients, which are potentially better suited for such devices. 23 Autologous fat transfer for breast augmentation is a growing sector and a still developing technology. [5] [6] [7] 11 The safety of the technique has been evaluated extensively. Groen et al conducted a systematic review including a large series of patients having received a cosmetic breast augmentation with autologous fat, and showed that complication rates and radiological findings are similar to those after implant-based breast augmentation. 24 In the setting of breast malignancies, as reported by Kronowitz et al, the only group in which the loco-regional cancer recurrence rate was higher in the lipofilling cohort was a subgroup treated with hormonal therapy. 25 The presented analysis revealed that autologous fat as a primary breast augmentation technique is used notably more often in Europe and Asia compared to the other countries. There was concern expressed by some respondents as write-in comments, that the technique does not have FDA approval and may cause legal problems (eg, Australia) due to the potential interference with breast cancer screening and the current lack of long-term experience.
Regarding ALCL, while the absolute risk of developing it is extremely low among women with implant mammoplasties (about 1 to 3 cases per million women), this malignancy occurs much more frequently in this group when compared with the general population (high relative risk). 26 Despite being so rare, it appears interesting that according to the presented survey 2% to 14% of all plastic surgeons have encountered a case of ALCL in their practice, underscoring the importance of continuous retro-and prospective data acquisition in order to allow for better risk stratification. A higher-risk patient population also includes Factor V Leiden patients. Affected heterozygote individuals have a 3 to 10 times higher risk for developing deep venous thrombosis compared with the general population. 27 Regardless, about half of surgeons would operate on such a patient using sequential compression devices at the very least, while adding anticoagulation/chemoprophylaxis as an additional preventive measure. Only in Asia, most surgeons would avoid performing a breast augmentation in a heterozygous patient, which might be due the extremely rare prevalence in that
Latin America (% of total respondents, n = 139) Europe (% of total respondents, n = 341) Asia (% of total respondents, n = 90) Oceania (% of total respondents, n = 58) Table 5 . Continued region and the associated lack of experience regarding prevention and treatment.
In the wide field of new technologies, many advances such as the introduction of ADMs, [28] [29] [30] insertion funnels, 31 or protective sheets have been described and promoted. Increased cost of the surgery and the lack of a clear consensus regarding their effectiveness might explain the international variation regarding the use of such products.
Trying to preoperatively determine implant size on tissue-based systems has several advantages over other methods like using externally applied sizers, rice bags, or similar. 32 The latter techniques remain the most commonly employed however, both in the United States and abroad. Three-dimensional imaging and preoperative surgical simulation have also been some of the newer emerging technologies, but have not caught on as one might have suspected and internationally, few surgeons use it. Compared to the United States, in other countries hardly any surgeons believe it to be a good marketing, educational, or preoperative sizing tool.
Besides implant shape, few issues surrounding breast augmentation have been discussed more extensively than those regarding filling material. In all surveyed countries, over 80% of surgeons use 100% silicone implants only, whereas in the United States only 20% use that type only. Generally, it has been shown that silicone implants appear to be safe with a high degree of patient satisfaction. 33 While better evidence from larger studies is still needed to clarify associations between silicone breast implants and health outcomes, 34, 35 silicone implants remain the internationally by far most preferred option. As over ten years have passed since silicone implants were reimplemented in the United States, the profound discrepancy cannot easily be explained. Also considering the use of textured vs smooth breast implants there were striking differences, with at least 80% of surgeons in Europe, Latin America, and Asia using mostly textured implant shell surfaces, while in the United States 85% of respondents use mostly or even exclusively smooth implants. This appears of interest, as textured implants tend to have lower rates of capsular contracture, less risk of displacement, and lower rates of infection. 36 However, they are currently thought to be associated with higher rates of ALCL development, as propagated by the ASPS and ASAPS. 37 Implant placement is another area of discordance, mostly regarding common practices in Latin America, where surgeons often use a subglandular or subfascial location. Originally described and popularized by Graf et al, 38 several subsequent Latin American studies have commented on the advantages of subfascial implant placement, which might explain why it is more popular in those countries. 39, 40 Current evidence regarding advantages of subfascial placement, however, is less conclusive. Despite not specifically commenting on subfascial placement, a recent meta-analysis performed by Egeberg et al evaluating the outcomes of 17,520 breast augmentations, showed that a subglandular implant placement increases the chances of developing a capsular contracture 2-fold compared to submuscular placement. [41] [42] [43] Ultimately, more data will be needed to better assess the value of subfascial implant placement. 44 In order to prevent infection and potentially also biofilm formation, use of prophylactic antibiotics perioperatively and during the postoperative phase is commonplace, despite the fact that while there exists strong evidence that patients undergoing clean aesthetic breast surgery benefit from routine prophylaxis, there is currently only weak evidence regarding optimal antibiotic dose and duration 45 or optimal irrigation type. 46 Measures for prevention of capsule formation were also surprisingly diverse. For instance, in the United States and Europe almost half the surgeons use pharmacologic agents to prevent or treat capsular contracture -regardless of the fact that 78% (United States) to 96% (Oceania) do not think that they work or are at least not sure about it, which goes in line with the little supportive evidence for such treatment. 47 Reoperations are not uncommon in breast augmentation surgery, and while capsular contracture and size change were uniformly the most common reasons to perform such operations in all countries except for Oceania, treatment approaches were very different. With ADMs mostly used in the United States to treat recurrent contractures, only when faced with double-bubble deformities or bottoming out do such matrices seem to play a major role in other countries.
While several noticeable findings could be elucidated, the presented survey analysis certainly also has several limitations. One lies in the nature of its design being an electronically disseminated questionnaire, with an overall moderate response rate of about 18%. While response rates are generally considered to be the most widely compared statistic for judging the quality of surveys, they are also one of the most controversial features, 48 especially as they have been declining, both in the United States and in most of the industrialized world, for at least several decades. 49 Several authors have consequently questioned their validity as a research method. 50 Nonetheless, according to the current literature, surveys remain to be a valuable tool to assess current trends and practice preferences in plastic surgery. In this setting, for most studies response rates seem to settle between 10% and 20%. [51] [52] [53] [54] [55] Another limitation lies in the fact that the survey was very detailed and rather lengthy to take, which might have imposed some bias as in the end potentially only surgeons with a particular interest in the matter completed all questions. Analysis did show however, that there were no significant correlations regarding number of performed procedures and preferences, and also not regarding surgeon experience, which was considerably high with over one third of respondents in all regions having reported a work experience of more than 20 years.
This study is also limited by the fact that no outcome measures were analyzed. To investigate patient outcomes based on nonstandardized questions appeared to be of little validity, however. Part of the assumption is therefore that surgeons employ the technique they feel most comfortable with, and which produces the best results in their hands.
In the end, surgeons will undoubtedly always need to customize their technique in respect to the individual patient, and therefore the presented common practices have to be seen in context of this limitation. However, assuming that patients are equally often different in all regions thus equally often requiring deviations from the standard approach, most preferred treatments still maintain their validity.
There exist many different approaches towards breast augmentation surgery, as illustrated, certainly also influenced by geographic and cultural factors. Nonetheless, while decision making is multifactorial, it is apparently not always made according to evidence base, as the latter should be universally accepted.
CONCLUSION
There exists accordance regarding several aspects of breast augmentation surgery, however international practice patterns remain very incoherent. While distinct techniques can already be advocated independent of location, plastic surgeons may still benefit from internationally applicable high-level studies in order to create standardized evidence-based practice guidelines and further improve outcomes.
